Hochschulschrift
Towards the Generation of novel Natural Killer Cell-based Immunotherapies against Melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Heidelberg, Universität Heidelberg, Dissertation, 2014
- Schlagwort
-
Melanoma
Killer cells
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Universitätsbibliothek Heidelberg
- (wann)
-
2014
- Urheber
- Beteiligte Personen und Organisationen
-
Umansky, Viktor
- DOI
-
10.11588/heidok.00016573
- URN
-
urn:nbn:de:bsz:16-heidok-165739
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Miller, Matthias
- Umansky, Viktor
- Universitätsbibliothek Heidelberg
Entstanden
- 2014
Ähnliche Objekte (12)
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Natural killer cell-based immunotherapy for acute myeloid leukemia
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Natural killer cell-based immunotherapy for acute myeloid leukemia
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Towards the generation of novel natural killer cell-based immunotherapies against melanoma
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
Molecular imaging biomarkers for cell-based immunotherapies
Development of NK cell-based cancer immunotherapies through receptor engineering
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
Natural killer cell-based immunotherapy for acute myeloid leukemia
In vitro and in vivo analysis of human cell-based immunotherapies for acute myeloid leukemia
Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies
Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review